Fig. 4From: Migraine induction with calcitonin gene-related peptide in patients from erenumab trialsProportion of patients who developed migraine-like attacks and headache after CGRP and placebo. More patients developed migraine-like attacks after CGRP (n = 10), compared to placebo (n = 0) (p = 0.002)Back to article page